Saegis Pharmaceuticals
Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders.
Launch date
Market cap
-
Enterprise valuation
CAD164—245m (Dealroom.co estimates Nov 2003.)
Half Moon Bay California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$14.0m | Series A | ||
$30.0m | Series B | ||
| Total Funding | CAD60.0m | ||
Related Content
Recent News about Saegis Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.